Hence then, the article about gannex announces first patient dosed in phase ii clinical trial of asc42 an fxr agonist for primary biliary cholangitis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Gannex Announces First Patient Dosed in Phase II Clinical Trial of ASC42, an FXR Agonist, for Primary Biliary Cholangitis )
Last updated :
Also on site :
- Firefighters rush to Morrisons convenience store in Oswestry after report of fire
- Today's Famous Celebrity Birthdays for March 22, 2026: Reese Witherspoon, William Shatner
- Iranian Revolutionary Guard: 200 Killed and Wounded Among Zionist Enemy in 73rd Wave